Dissolved and financials
CVR: 26290724
DKK -157,000
Gross profit
Net result: DKK 101,458,000
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 22 December 2025
CVR · view overview
0 employees
CVR · 2011
Director role ended: NORDIC BIOTECH GENERAL PARTNER ApS
CVR · 22/12/2025
View the full event history
NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202401/01/2024 – 31/12/2024 | -157 t. | 101.5 mio. | 127.1 mio. | 127 mio. | - | |
| 202301/01/2023 – 31/12/2023 | -133 t. | 1.3 mio. | 32.3 mio. | 32.2 mio. | - | |
| 202201/01/2022 – 31/12/2022 | - | -44.6 mio. | 34.2 mio. | 34.1 mio. | 0 | |
| 202101/01/2021 – 31/12/2021 | - | -6.4 mio. | 78.8 mio. | 78.7 mio. | 0 | |
| 202001/01/2020 – 31/12/2020 | - | -1.4 mio. | 85.2 mio. | 85.1 mio. | 0 | |
| 201901/01/2019 – 31/12/2019 | - | 13 mio. | 86.6 mio. | 86.5 mio. | 0 | |
| 201801/01/2018 – 31/12/2018 | - | -464.7 mio. | 73.6 mio. | 73.5 mio. | - | |
| 201701/01/2017 – 31/12/2017 | - | 149.6 mio. | 538.4 mio. | 538.1 mio. | - | |
| 201601/01/2016 – 31/12/2016 | - | -1.1 mia. | 2.3 mia. | 2.3 mia. | - | |
| 201501/01/2015 – 31/12/2015 | - | 317.4 mio. | 3.4 mia. | 3.4 mia. | - | |
| 201401/01/2014 – 31/12/2014 | -44 t. | 2 mia. | 3 mia. | 3 mia. | - | |
| 201301/01/2013 – 31/12/2013 | -2.8 mio. | 302.5 mio. | 1 mia. | 1 mia. | - | |
| 201201/01/2012 – 31/12/2012 | - | 571.2 mio. | 724 mio. | 723.8 mio. | - |
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. NORDIC BIOTECH K/S is registered in the Danish CVR register with the status Dissolved and ceased on 22 December 2025.
The CVR number of NORDIC BIOTECH K/S is 26290724.
In 2024, NORDIC BIOTECH K/S reported a gross profit of DKK -157,000.
NORDIC BIOTECH K/S had 0 employees in 2011 according to the Danish CVR register.
NORDIC BIOTECH K/S was founded on 28 September 2001.
NORDIC BIOTECH K/S was registered under the industry Anden finansiel formidling i.a.n. (industry code 649990).
As of December 22, 2025, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NORDIC BIOTECH K/S.
As of December 22, 2025, NORDIC BIOTECH GENERAL PARTNER ApS has stepped down as director of NORDIC BIOTECH K/S.
NORDIC BIOTECH K/S was dissolved on December 22, 2025.
NORDIC BIOTECH K/S has published its annual report for 2024. Gross profit came to DKK -157,000, and the net result was DKK 101,458,000.
NORDIC BIOTECH K/S has published its annual report for 2023. Gross profit came to DKK -133,000, and the net result was DKK 1,254,000.
NORDIC BIOTECH K/S has published its annual report for 2022. The net result was DKK -44,572,000.
As of June 12, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of NORDIC BIOTECH K/S.
As of June 12, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of NORDIC BIOTECH K/S.
NORDIC BIOTECH K/S has published its annual report for 2021. The net result was DKK -6,387,000.
NORDIC BIOTECH K/S has published its annual report for 2020. The net result was DKK -1,360,000.
NORDIC BIOTECH K/S has published its annual report for 2019. The net result was DKK 12,997,000.
NORDIC BIOTECH K/S has published its annual report for 2018. The net result was DKK -464,676,000.
NORDIC BIOTECH K/S has published its annual report for 2017. The net result was DKK 149,646,000.
NORDIC BIOTECH K/S has published its annual report for 2016. The net result was DKK -1,098,813,000.
NORDIC BIOTECH K/S has published its annual report for 2015. The net result was DKK 317,378,000.
NORDIC BIOTECH K/S has published its annual report for 2014. Gross profit came to DKK -44,000, and the net result was DKK 2,030,926,000.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of NORDIC BIOTECH K/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of NORDIC BIOTECH K/S.
NORDIC BIOTECH K/S has published its annual report for 2013. Gross profit came to DKK -2,836,000, and the net result was DKK 302,522,000.
NORDIC BIOTECH K/S has published its annual report for 2012. The net result was DKK 571,212,498.
As of July 5, 2012, JUT NR. 2180 A/S has been appointed auditor of NORDIC BIOTECH K/S.
As of July 5, 2012, EY Danmark A/S has stepped down as auditor of NORDIC BIOTECH K/S.
As of June 17, 2003, Claus Tycho Bræstrup has stepped down as investerings komite of NORDIC BIOTECH K/S.
As of June 17, 2003, Lars Grønborg Eskesen has stepped down as investerings komite of NORDIC BIOTECH K/S.
As of June 17, 2003, Maja Kirstine Elsøe has stepped down as investerings komite of NORDIC BIOTECH K/S.
As of June 17, 2003, Matthew Daniel Perry has stepped down as investerings komite of NORDIC BIOTECH K/S.
As of June 20, 2002, Claus Tycho Bræstrup has joined the board of directors of NORDIC BIOTECH K/S.
As of June 20, 2002, Maja Kirstine Elsøe has joined the board of directors of NORDIC BIOTECH K/S.
As of June 20, 2002, Matthew Daniel Perry has joined the board of directors of NORDIC BIOTECH K/S.
As of June 20, 2002, Claus Tycho Bræstrup has left the board of directors of NORDIC BIOTECH K/S.
As of June 20, 2002, Maja Kirstine Elsøe has left the board of directors of NORDIC BIOTECH K/S.
As of June 20, 2002, Matthew Daniel Perry has left the board of directors of NORDIC BIOTECH K/S.
As of June 20, 2002, Claus Tycho Bræstrup is registered as investerings komite of NORDIC BIOTECH K/S.
As of June 20, 2002, Lars Grønborg Eskesen is registered as chairman of NORDIC BIOTECH K/S.
As of June 20, 2002, Lars Grønborg Eskesen is registered as investerings komite of NORDIC BIOTECH K/S.
As of June 20, 2002, Maja Kirstine Elsøe is registered as investerings komite of NORDIC BIOTECH K/S.
As of June 20, 2002, Matthew Daniel Perry is registered as investerings komite of NORDIC BIOTECH K/S.
As of June 20, 2002, Lars Grønborg Eskesen has stepped down as chairman of NORDIC BIOTECH K/S.
As of September 28, 2001, EY Danmark A/S has been appointed auditor of NORDIC BIOTECH K/S.
As of September 28, 2001, NORDIC BIOTECH GENERAL PARTNER ApS is registered as director of NORDIC BIOTECH K/S.
NORDIC BIOTECH K/S was founded on September 28, 2001.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 26490790
CVR 39064553
CVR 41064110
CVR 10068959
CVR 19133338
